GreenLight Clinical investigates the increasing incidence of sight-threatening diseases and looks further into some of these conditions. They include Age-Related Macular Degeneration, Wet Age-related Macular Degeneration, Dry Eye Disease, Glaucoma, Cataract, Retinal Detachment, and Diabetic Retinopathy. Dr. Andrew Chang, Founder, and Chairman of GreenLight Clinical is a pre-eminent vitreoretinal surgeon in Australia and Asia-Pacific.
